An open-label, dose-escalation study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of single doses of GSK2586881 in participants with pulmonary arterial hypertension - Simon, Marc; Hanrott, Kate; Budd, David C.; Torres, Fernando; Grünig, Ekkehard; Escribano-Subias, Pilar; Meseguer, Manuel L.; Halank, Michael; Opitz, Christian; Hall, David A.; Hewens, Deborah; Powley, William M.; et al. (Pulmonary circulation, 2022)
Gesehen am 30.01.2023